Detalhe da pesquisa
1.
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer.
Cell
; 173(7): 1755-1769.e22, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29754820
2.
Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.
Proc Natl Acad Sci U S A
; 118(41)2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615710
3.
Profiling the immune landscape in mucinous ovarian carcinoma.
Gynecol Oncol
; 168: 23-31, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368129
4.
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer.
Gynecol Oncol
; 160(2): 520-529, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33342620
5.
The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers.
Gynecol Oncol
; 158(1): 167-177, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446718
6.
Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma.
BMC Cancer
; 17(1): 618, 2017 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870260
7.
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
Gynecol Oncol
; 141(2): 293-302, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26972336
8.
Recurrent genomic rearrangements in primary testicular lymphoma.
J Pathol
; 236(2): 136-41, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712539
9.
Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease.
J Pathol
; 229(4): 515-24, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22996961
10.
VOLTA: an enVironment-aware cOntrastive ceLl represenTation leArning for histopathology.
Nat Commun
; 15(1): 3942, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729933
11.
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.
Cancer Cell
; 42(6): 1003-1017.e6, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38861923
12.
Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma.
J Clin Oncol
; 42(9): 1077-1087, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113419
13.
A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma.
Front Oncol
; 13: 1286754, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38188285
14.
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.
Nat Genet
; 55(3): 437-450, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849657
15.
The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.
Clin Cancer Res
; 29(17): 3471-3483, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339172
16.
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.
Mod Pathol
; 25(5): 740-50, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22282309
17.
Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes.
J Transl Med
; 10: 33, 2012 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22369276
18.
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.
Breast Cancer Res
; 13(6): R126, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22151962
19.
Avelumab in newly diagnosed glioblastoma.
Neurooncol Adv
; 3(1): vdab118, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34604752
20.
Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells.
Commun Biol
; 4(1): 859, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253827